Delta Drone International Ltd (AU:RKT)
ASX:RKT
Top Page
Delta Drone International Ltd
(Sydney:RKT)
Select Model
Select Model
Rating:52Neutral
Price Target:
AU$0.03
â–²(65.00% Upside)
Action:ReiteratedDate:01/09/26
The score is held back primarily by weak fundamentals—persistent losses and ongoing negative free cash flow—despite manageable leverage. This is partially offset by strong technical momentum (price above key moving averages with positive MACD). Valuation is penalized due to a negative P/E and no dividend support.
Positive Factors
Revenue Growth
Sustained topline growth over multiple years indicates expanding commercial traction in enterprise drone services. Durable revenue expansion supports scale economics, improves prospects for margin recovery and reduces dependence on one-off project work as recurring services scale.
Negative Factors
Negative Free Cash Flow
Persistent negative free cash flow forces reliance on equity or debt financing to fund operations and growth. Over months this constrains capital allocation, limits ability to invest in product development or scale teams, and raises dilution or refinancing risk if losses continue.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained topline growth over multiple years indicates expanding commercial traction in enterprise drone services. Durable revenue expansion supports scale economics, improves prospects for margin recovery and reduces dependence on one-off project work as recurring services scale.
Read all positive factors
Delta Drone International Ltd (RKT) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$22.67M
Dividend YieldN/A
Average Volume (3M)6.08M
Price to Earnings (P/E)―
Beta (1Y)1.39
Revenue GrowthN/A
EPS GrowthN/A
CountryAU
EmployeesN/A
SectorTechnology
Sector Strength88
IndustryComputer Hardware
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,193,307,900
10 Day Avg. Volume9,789,492
30 Day Avg. Volume6,081,740
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)1.38
Price to Sales (P/S)1.18
P/FCF Ratio-4.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Delta Drone International Ltd Business Overview & Revenue Model
Company Description
RocketDNA Ltd. engages in the provision of drone-based geo-data and automation solutions for the mining, agriculture, and critical asset industries in Australia and South Africa. The company offers contract aerial surveying and mapping; surveillan...
How the Company Makes Money
null...
Delta Drone International Ltd Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
58
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.09M | 7.24M | 6.14M | 5.73M | 4.58M |
| Gross Profit | 2.94M | 3.64M | 3.13M | 2.80M | 2.43M |
| EBITDA | -1.47M | -1.03M | -1.43M | -1.98M | -1.63M |
| Net Income | -2.32M | -1.92M | -1.77M | -1.92M | -3.62M |
Balance Sheet | |||||
| Total Assets | 8.10M | 8.35M | 6.81M | 6.97M | 10.28M |
| Cash, Cash Equivalents and Short-Term Investments | 1.74M | 3.45M | 2.38M | 2.31M | 989.78K |
| Total Debt | 1.70M | 1.34M | 1.17M | 380.78K | 733.04K |
| Total Liabilities | 3.12M | 2.50M | 2.18M | 1.32M | 3.55M |
| Stockholders Equity | 5.26M | 6.18M | 4.92M | 5.59M | 8.04M |
Cash Flow | |||||
| Free Cash Flow | -2.80M | -1.73M | -1.90M | -2.34M | -2.43M |
| Operating Cash Flow | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 |
| Investing Cash Flow | -1.99M | -1.16M | -56.51K | 3.25M | -498.27K |
| Financing Cash Flow | 3.23M | 2.72M | 1.12M | -355.46K | -165.27K |
Delta Drone International Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
53 Neutral | AU$9.88M | -13.48 | -119.80% | ― | 106.54% | 74.33% | |
52 Neutral | AU$22.67M | -1.97 | -40.51% | ― | ― | ― | |
50 Neutral | AU$15.56M | 0.92 | 26.81% | ― | -21.60% | -657.00% | |
49 Neutral | AU$11.77M | -16.86 | -2.67% | ― | 24.43% | 40.63% | |
45 Neutral | AU$6.44M | -3.48 | -658.94% | ― | 13.07% | 68.60% |
* Technology Sector Average
AU:RKT
Delta Drone International Ltd
0.02
0.01
100.00%
AU:1CG
UUV Aquabotix Ltd.
0.01
0.00
0.00%
AU:BCC
Beam Communications Holdings Limited
0.18
0.09
95.65%
AU:WHK
WhiteHawk Ltd.
0.01
-0.02
-66.67%
AU:REM
RemSense Technologies Ltd.
0.05
>-0.01
-16.67%
Delta Drone International Ltd Corporate Events
RocketDNA launches Skylink OS with Tier-1 miner to scale autonomous drone operations
Mar 11, 2026
RocketDNA Ltd has launched its proprietary Skylink operating system platform into an initial live testing phase with an existing Tier-1 global mining customer, marking a key step in scaling its remote drone operations. The Skylink OS provides a ce...
RocketDNA Files Updated Corporate Governance Statement with ASX
Feb 25, 2026
RocketDNA Limited is an ASX-listed company that has lodged its corporate governance documentation for the financial year ended 31 December 2025. The company operates under the ASX Corporate Governance Council’s Principles and Recommendations...
RocketDNA updates corporate governance framework to align with ASX principles
Feb 25, 2026
RocketDNA Limited has released an updated corporate governance statement, confirming that its board remains responsible for overseeing the company’s management and safeguarding shareholder interests. The board has adopted the ASX Corporate G...
RocketDNA lifts revenue but posts deeper annual loss and holds dividends
Feb 25, 2026
RocketDNA Ltd reported a modest 6% rise in revenue to $7.683 million for the year to 31 December 2025, but its net loss attributable to members widened to $2.815 million, a 46% deterioration from the prior year. The company did not declare any div...
RocketDNA Issues 5 Million Unquoted Options as Part of Prior Transaction
Jan 19, 2026
RocketDNA Ltd has notified the market of the issue of 5,000,000 unquoted options under ASX code RKTAB, each exercisable at $0.02 and expiring on 30 May 2029, with an issue date of 19 January 2026. The new options, which are not intended to be quot...
RocketDNA Sets Terms for 5 Million Consultant Options
Jan 19, 2026
RocketDNA Ltd has detailed the terms and conditions of 5,000,000 consultant options previously notified as a proposed issue of securities, each option carrying an exercise price of $0.02 and expiring on 30 May 2029. The options vest on 1 July 2026...
RocketDNA Lodges Plan to Issue 5 Million Long-Dated Options
Jan 18, 2026
RocketDNA Ltd., listed on the ASX under the code RKT, has lodged a notice with the exchange outlining a proposed issue of new securities via a placement or similar capital-raising mechanism. The company did not include additional operational or st...
RocketDNA Triggers Milestone Vesting of 2025 Executive Performance Rights
Jan 11, 2026
RocketDNA Ltd has announced that a performance milestone has been met, triggering the vesting of 4 million 2025 Performance Rights held by Managing Director Chris Clark and 2 million held by executive director Paul Williamson. The milestone was ac...
RocketDNA Issues New Shares Under Employee Incentive Plan
Jan 7, 2026
RocketDNA Ltd has issued 617,984 fully paid ordinary shares to employees under its Employee Incentive Plan, expanding its share capital without undertaking a formal prospectus or disclosure process under Part 6D.2 of the Corporations Act. The comp...
RocketDNA Grants 4.5 Million Performance Rights Under 2025 Employee Incentive Plan
Jan 7, 2026
RocketDNA Ltd has notified the market of the issuance of 4.5 million unquoted performance rights to employees under its 2025 employee incentive scheme, effective 7 January 2026. The move underscores the company’s use of equity-based remunera...
RocketDNA Seeks ASX Quotation for New Shares Issued Under Employee Incentive Plan
Jan 7, 2026
RocketDNA Ltd. has applied to the ASX for quotation of 617,984 new fully paid ordinary shares, issued on 7 January 2026 under its employee incentive plan approved by shareholders in May 2024. The move modestly increases the company’s quoted ...
RocketDNA Executives Secure Full Vesting of Performance Rights After 100% TSR Milestone
Jan 5, 2026
RocketDNA Ltd has announced that a performance milestone has been met, triggering the full vesting of 3,000,000 performance rights held by Managing Director and CEO Chris Clark and 1,500,000 performance rights held by executive director Paul Willi...
Pither Investments and Nintieth Y Exit Substantial Holder Position in Rocketdna
Dec 30, 2025
Pither Investments Pty Ltd and Nintieth Y Pty Ltd have ceased to be substantial shareholders in Rocketdna Ltd, as disclosed in a statutory notice lodged under the Corporations Act. The change, effective 24 December 2025 and attributed to dilution ...
RocketDNA Director Paul Williamson Increases Stake Through Share Placement
Dec 24, 2025
RocketDNA Ltd has disclosed a change in the holdings of director Paul Williamson, who acquired 1,333,333 ordinary fully paid shares on 24 December 2025 through participation in the second tranche of a shareholder-approved placement. Following the ...
RocketDNA Director David Morton Increases Indirect Shareholding
Dec 24, 2025
RocketDNA Ltd has disclosed a change in director David Morton’s indirect interest in the company’s securities, as required under ASX listing rules. Through an associated holder, Morton acquired 6,666,666 additional ordinary fully paid ...
RocketDNA Director Chris Clark Increases Indirect Shareholding via Placement
Dec 24, 2025
RocketDNA Ltd has disclosed a change in the interests of director Chris Clark, whose holdings are held indirectly via C K Clark SMSF Pty Ltd. Clark acquired 666,666 additional ordinary fully paid shares for $10,000 through participation in tranch...
RocketDNA Issues 45 Million New Shares Under Approved Placement
Dec 24, 2025
RocketDNA Ltd has issued 45,199,993 new ordinary fully paid shares at $0.015 per share as part of a placement previously announced to the market and approved by shareholders at a recent general meeting. The company confirmed that the shares were i...
RocketDNA Seeks ASX Quotation for 45.2 Million New Shares
Dec 24, 2025
RocketDNA Ltd has applied to the ASX for quotation of 45,199,993 new fully paid ordinary shares under code RKT, following the issue of these securities on 24 December 2025. The move expands the company’s quoted capital base and formalises th...
RocketDNA to Brief Investors on Contracts, BHP Deployment and 2026 Priorities
Dec 22, 2025
RocketDNA Ltd has invited shareholders and interested investors to an online webinar on 23 December 2025, where Managing Director and CEO Christopher Clark will brief the market on recent operational progress and customer activity. The session wil...
RocketDNA Passes Key Resolutions in General Meeting
Dec 18, 2025
RocketDNA Ltd announced the successful passage of all resolutions at its General Meeting held on December 18, 2025. The resolutions, including the ratification and approval of recent share placements, signal stakeholder confidence and provide the ...
RocketDNA Secures A$1M in New Orders, Expands Drone Deployments
Dec 17, 2025
RocketDNA Ltd has secured approximately A$1 million in new orders from existing clients, reflecting a growing demand for their autonomous drone solutions in the mining sector. The company has expanded its xBot deployments across Australia and secu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.